Why Your GPO Isn't Getting You the Best Perfusion Pricing

Most administrators assume their group purchasing organization has already secured competitive pricing on perfusion supplies. For high-volume commodities, that assumption is often fair. For specialized cardiovascular perfusion products, it frequently is not — and the belief that it is prevents anyone from looking closer.

Where GPO leverage comes from — and where it fades

A GPO's power comes from aggregating demand for standardized products across many hospitals. That model works beautifully for gloves and gauze. It works poorly for perfusion, where product selection is clinically driven, volumes per item are lower, and a handful of manufacturers dominate. Aggregated leverage weakens precisely where clinical specificity is highest.

The gaps that open up

What to do about it

The point is not to abandon the GPO — it is to verify, item by item, where GPO pricing actually applies to your perfusion spend and where it does not. The items that fall through the gaps are where independent benchmarking and direct negotiation recover real money. "We're covered by our GPO" is a hypothesis, not a fact, until someone checks the line items.